1. Nektar Therapeutics Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.

    Nektar Therapeutics Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.

    SAN FRANCISCODec. 17, 2019 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced it has appointed Myriam J. Curet, M.D., as an independent director to its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned